Tmunity

Closed

Next-generation T-cell therapies for cancer.

Philadelphia, United States · Founded 2015 · $185.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$185.0M
Last Round
$75.0M Venture RoundDec 2022
Rounds
4

About

Tmunity Therapeutics developed next-generation engineered T-cell therapies (CAR-T and TCR-T) for solid tumors and hematologic malignancies in oncology. The company collaborated with biopharma partners and clinical centers before being acquired by Kite, a Gilead Company.

Summary

Tmunity is a Biotech company based in Philadelphia, United States, founded in 2015. It has raised $185.0M in total across 4 rounds, most recently a $75.0M Venture Round round in Dec 2022. Investors include Parker Institute for Cancer Immunotherapy, Andreessen Horowitz and Gilead Sciences.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundSeries CDec 2022

Sign up to see all 4 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tmunity on Indexed.vc
<a href="https://indexed.vc/companies/tmunity"><img src="https://indexed.vc/api/badge/company/tmunity" alt="Tmunity on Indexed.vc" width="260" height="76" /></a>